Prognostic models for stage I-III esophageal cancer: a comparison between existing calculators

被引:5
|
作者
Lemini, Riccardo [1 ]
Vico, Tamara Diaz [1 ]
Trumbull, Denslow A. [2 ]
Attwood, Kristopher [3 ]
Spaulding, Aaron C. [4 ]
Elli, Enrique F. [1 ]
Colibaseanu, Dorin T. [1 ]
Kukar, Moshim [5 ]
Gabriel, Emmanuel [1 ]
机构
[1] Mayo Clin, Dept Surg, Jacksonville, FL 32224 USA
[2] Univ Florida, Coll Med, Gainesville, FL USA
[3] Roswell Park Comprehens Canc Ctr, Dept Biostat, Buffalo, NY USA
[4] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA
[5] Roswell Park Comprehens Canc Ctr, Dept Surg Oncol, Buffalo, NY USA
关键词
Esophageal cancer; overall survival (OS); calculator; nomogram; neoadjuvant chemoradiation; BODY-MASS INDEX; NEOADJUVANT CHEMORADIOTHERAPY; PERIOPERATIVE CHEMOTHERAPY; PREDICTS SURVIVAL; COLON-CANCER; LYMPH-NODES; SURGERY; ADENOCARCINOMA; NOMOGRAM; CHEMORADIATION;
D O I
10.21037/jgo-20-337
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Determining the best approach for esophageal cancer and predicting accurate prognosis are critical. Multiple studies evaluated characteristics associated with overall survival, and several prediction models have been developed. This study aimed to evaluate existing models and perform external validation of selected models. Methods: A retrospective investigation of a multi-site institutional enterprise for patients with a diagnosis of esophageal cancer between 2013-2014 was performed. Selected survival prediction models included the Roswell Park Comprehensive Cancer Center (RPCCC) calculator, Oregon Health & Science University (OHSU) calculator, and two nomograms published by Shapiro et al. and Sun et al. One-year overall survival, level of agreement, and performance for each model were evaluated. Results: A total of 104 patients were included and used to assess the prediction models. One-year overall survival was 0.76. Different calculators tended to rank patients similarly; however, they did not agree on predicted overall survival. The least disparity in correlation was observed between OHSU and Shapiro calculators. Shapiro's model achieved the highest performance [area under the curve (AUC) =0.63]. Conclusions: Selected models showed fair results in estimating individual overall survival, although none achieved a high performance. While these tools may support the decision-making process for esophageal cancer patients, their implementation in clinical practice requires improved refinement to optimize their clinical utility.
引用
收藏
页码:1963 / 1972
页数:10
相关论文
共 50 条
  • [21] Prognostic significance of stromal SMYD3 expression in colorectal cancer of TNM stage I-III
    Liu, Naiqing
    Sun, Shuxiang
    Yang, Xiaoqing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (08): : 8901 - 8907
  • [22] Stage II-III colon cancer: a comparison of survival calculators
    Lemini, Riccardo
    Attwood, Kristopher
    Pecenka, Stacey
    Grego, Juliet
    Spaulding, Aaron C.
    Nurkin, Steven
    Colibaseanu, Dorin T.
    Gabriel, Emmanuel
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (06) : 1091 - 1098
  • [23] Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer
    Mell, LK
    Meyer, JJ
    Tretiakova, M
    Khramtsov, A
    Gong, C
    Yamada, SD
    Montag, AG
    Mundt, AJ
    CLINICAL CANCER RESEARCH, 2004, 10 (16) : 5546 - 5553
  • [24] Prognostic Value of the Uric Acid Level and Its Effect on Survival in Stage I-III Gastric Cancer
    Ustuner, Mehmet Akif
    Karaman, Niyazi
    Aksel, Bulent
    Dogan, Lutfi
    CYPRUS JOURNAL OF MEDICAL SCIENCES, 2019, 4 (03): : 169 - 172
  • [25] Adjuvant Chemotherapy for Resected Stage II and III Colon Cancer: Comparison of Two Widely Used Prognostic Calculators
    Bardia, Aditya
    Loprinzi, Charles
    Grothey, Axel
    Nelson, Garth
    Alberts, Steven
    Menon, Smitha
    Thome, Stephan
    Gill, Sharlene
    Sargent, Dan
    SEMINARS IN ONCOLOGY, 2010, 37 (01) : 39 - 46
  • [26] Prognostic value of an autophagy-related signature for early relapse in stage I-III colon cancer
    Mo, S.
    Dai, W.
    Li, Y.
    Feng, Y.
    Zhang, L.
    Li, Q.
    Cai, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [27] Survival of clinical stage I-III rectal cancer patients: a population-based comparison
    Joye, I.
    Silversmit, G.
    Van Eycken, E.
    Debucquoy, A.
    Vandendael, T.
    Penninckx, F.
    Haustermans, K.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S108 - S109
  • [28] Treatment of stage I-III periodontitis
    Reena Wadia
    British Dental Journal, 2020, 229 (6) : 375 - 375
  • [29] Adjuvant chemotherapy for resected stage II and III colon cancer: Comparison of widely used two prognostic calculators
    Bardia, A.
    Loprinzi, C.
    Grothey, A.
    Nelson, G.
    Alberts, S.
    Patiyil, S.
    Thome, S.
    Gill, S.
    Sargent, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] Prognostic Value of Radiotherapy and Chemotherapy in Stage I-III Merkel Cell Carcinoma
    Bi, Aihong
    Yang, Sifu
    Ding, Yang
    Yu, Yong
    Zhan, Wenming
    Song, Tao
    FRONTIERS IN MEDICINE, 2022, 9